Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results

Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days after vaccination. Methods: We reviewed all the pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Andrea, Bozzi, Giorgio, Ungaro, Riccardo, Villa, Simone, Castelli, Valeria, Mangioni, Davide, Muscatello, Antonio, Gori, Andrea, Bandera, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994748/
https://www.ncbi.nlm.nih.gov/pubmed/33777055
http://dx.doi.org/10.3389/fimmu.2021.657711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994748/
https://www.ncbi.nlm.nih.gov/pubmed/33777055
http://dx.doi.org/10.3389/fimmu.2021.657711

Ejemplares similares